These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

122 related articles for article (PubMed ID: 1589383)

  • 1. Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA.
    Adebajo AO; Crisp AJ; Nicholls A; Hazleman BL
    Postgrad Med J; 1992 Mar; 68(797):216-8. PubMed ID: 1589383
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Localized scleroderma and hemiatrophy in association with antibodies to double-stranded DNA.
    Larner AJ
    Postgrad Med J; 1993 Feb; 69(808):166. PubMed ID: 8506209
    [No Abstract]   [Full Text] [Related]  

  • 3. Antinuclear antibodies in localized scleroderma.
    Takehara K; Moroi Y; Nakabayashi Y; Ishibashi Y
    Arthritis Rheum; 1983 May; 26(5):612-6. PubMed ID: 6405756
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Radiochemical demonstration of serum antibodies against double stranded DNA in progressive and circumscribed scleroderma].
    Meffert H; Falck P; Sönnichsen N
    Dermatol Wochenschr; 1975 Sep; 161(9):771-2. PubMed ID: 1081055
    [No Abstract]   [Full Text] [Related]  

  • 5. Anti-single-stranded DNA antibody and muscle involvement in localized scleroderma.
    Takehara K; Kikuchi K; Soma Y; Igarashi A; Ishibashi Y
    Arch Dermatol; 1990 Oct; 126(10):1368. PubMed ID: 2221947
    [No Abstract]   [Full Text] [Related]  

  • 6. [Immunologic changes in linear scleroderma in children. Apropos of 11 cases].
    Fontan I; Taïeb A; Guillet G; Rommel A; Fontan D; Maleville J
    Ann Dermatol Venereol; 1988; 115(2):135-41. PubMed ID: 3293512
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Antinuclear antibodies and anti-DNA antibodies in scleroderma. A possible relationship between joint manifestations and increased antibodies in localized scleroderma.
    Serup J; Staun-Olsen P
    Allergy; 1986 Aug; 41(6):452-6. PubMed ID: 3491549
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Antinuclear antibodies in localized scleroderma].
    Takehara K; Nakabayashi Y; Ishibashi Y; Moroi Y
    Nihon Hifuka Gakkai Zasshi; 1982; 92(8):883-8. PubMed ID: 6816966
    [No Abstract]   [Full Text] [Related]  

  • 9. Antinuclear and anti-single-stranded DNA antibodies in morphea and generalized morphea.
    Falanga V; Medsger TA; Reichlin M
    Arch Dermatol; 1987 Mar; 123(3):350-3. PubMed ID: 3545090
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Prevalence and characteristics of anti-single-stranded DNA antibodies in localized scleroderma. Comparison with systemic lupus erythematosus.
    Ruffatti A; Peserico A; Rondinone R; Calligaro A; Del Ross T; Ghirardello A; Germino M; Todesco S
    Arch Dermatol; 1991 Aug; 127(8):1180-3. PubMed ID: 1863075
    [TBL] [Abstract][Full Text] [Related]  

  • 11. [The antinuclear antibody spectrum in circumscribed forms of scleroderma].
    do Vale E; Gerstmeier H; Meurer M; Krieg T; Braun-Falco O
    Dtsch Med Wochenschr; 1986 Dec; 111(50):1922-7. PubMed ID: 3536401
    [TBL] [Abstract][Full Text] [Related]  

  • 12. [Antinuclear antibodies in mesenchymal scleroderma and progressive systemic sclerosis (author's transl)].
    Sugiura M; Hashimoto T; Kurihara S; Nishikawa T; Hatano H
    Nihon Hifuka Gakkai Zasshi; 1980 Sep; 90(10):935-7. PubMed ID: 7012401
    [No Abstract]   [Full Text] [Related]  

  • 13. Antihistone antibodies in patients with localized scleroderma.
    Sato S; Ihn H; Soma Y; Igarashi A; Tamaki T; Kikuchi K; Ishibashi Y; Takehara K
    Arthritis Rheum; 1993 Aug; 36(8):1137-41. PubMed ID: 8343189
    [TBL] [Abstract][Full Text] [Related]  

  • 14. [Immunologic abnormalities in localized scleroderma].
    Takehara K; Nakabayashi Y; Ishibashi Y; Moroi Y; Aikawa T; Inaba K; Meshizuka K
    Nihon Hifuka Gakkai Zasshi; 1984 Feb; 94(2):121-8. PubMed ID: 6610780
    [No Abstract]   [Full Text] [Related]  

  • 15. Proceedings: Serologic abnormalities and their significance in localized scleroderma.
    Scarola JA; Shulman LE
    Arthritis Rheum; 1975; 18(5):526. PubMed ID: 1081397
    [No Abstract]   [Full Text] [Related]  

  • 16. Antinuclear antibodies in localized scleroderma: unique staining in chromosome spreads.
    Kikuchi K; Takehara K; Ishibashi Y
    J Am Acad Dermatol; 1989 Dec; 21(6):1301-3. PubMed ID: 2685065
    [No Abstract]   [Full Text] [Related]  

  • 17. [Indications of the systemic character of circumscript scleroderma in children and adolescents].
    Albrecht-Nebe H; Eggert W; Ziegler H; Barthelmes H; Wolf S
    Dermatol Monatsschr; 1987; 173(3):123-30. PubMed ID: 3496247
    [No Abstract]   [Full Text] [Related]  

  • 18. [Immunofluorescent studies in patients with scleroderma and in their families].
    Szczepański A
    Przegl Dermatol; 1972; 59(6):727-32. PubMed ID: 4566145
    [No Abstract]   [Full Text] [Related]  

  • 19. Some immunologic considerations in focal scleroderma and progressive systemic sclerosis in children.
    Hanson V; Kornreich HK; Drexler E; Johnson GD; Macpherson GA
    Pediatr Res; 1974 Sep; 8(9):806-9. PubMed ID: 4213387
    [No Abstract]   [Full Text] [Related]  

  • 20. [Localized scleroderma and PSS specific anti-Og antibody (author's transl)].
    Nishikawa T; Kurihara S; Sugiura M; Shimizu H; Tojo T
    Nihon Hifuka Gakkai Zasshi; 1981 Jul; 91(8):859-60. PubMed ID: 6976462
    [No Abstract]   [Full Text] [Related]  

    [Next]    [New Search]
    of 7.